뉴멕시코의 암 (전체) 임상 시험
암 (전체) 관련 연구 16개가 뉴멕시코 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴멕시코의 도시
공식 연구 텍스트(영어)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- University of New Mexico Cancer Center, Albuquerque
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of New Mexico, School of Medicine, Albuquerque
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of New Mexico Cancer Center, Albuquerque
- Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of New Mexico Comprehensive Cancer Center, Albuquerque
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- University of New Mexico Comprehensive Cancer Center, Albuquerque
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT03977402Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- University of New Mexico Comprehensive Cancer Center, Albuquerque
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06207864A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Albuquerque
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT05123482TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- The University of New Mexico Comprehensive Cancer Center, Albuquerque
- 외 2개
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535Project: Every Child for Younger Patients With Cancer
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 292, Albuquerque
피험자 모집 중2상
18세 이상 · 여성 · 2026. 7. 16. 업데이트됨 · NCT06906341A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Christus St Vincent Regional Medical Center, Santa Fe
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 15. 업데이트됨 · NCT06657144Molecular Genetics Studies of Cancer Patients and Their Relatives
- Lovelace Medical Center-Downtown, Albuquerque
- New Mexico Oncology Hematology Consultants, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
피험자 모집 중관찰 연구건강한 지원자 환영
전 연령 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT04185935Caris Biorepository Research Protocol
- CHRISTUS - St. Vincent Regional Cancer Center, Santa Fe
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 1. 21. 업데이트됨 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Albuquerque
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
- New Mexico Oncology Hematology Consultants, Albuquerque
피험자 모집 중관찰 연구건강한 지원자 환영
18세 ~ 120세 · 모든 성별 · 2025. 10. 20. 업데이트됨 · NCT06877884Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Lovelace Medical Centre-Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
피험자 모집 중
18세 이상 · 모든 성별 · 2024. 11. 27. 업데이트됨 · NCT03860883ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.